芝商所：CME Direct断开和连接问题现已解决。

CFTC: for the week to June 16, speculators raised net short positions in CBOT US 2-year Treasury futures by 50,669 contracts to 1,270,507 contracts and increased net short in CBOT US 10-year Treasury futures by 47,275 contracts to 911,082 contracts.

June 22 — China’s National Medical Products Administration approved Pulai Pharmaceutical (Jiangsu) Co., Ltd.’s Class 1 innovative drug Peilaiganan topical spray (brand PuyiKe) for marketing. The topical antibacterial is indicated for secondary wound infections in grade I or superficial grade II burns and scalds caused by Staphylococcus epidermidis, hemolytic staphylococci and Acinetobacter baumannii.